Mediair Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 3.61 Cr
as on 24-10-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.02 Cr
as on 24-10-2024
- Revenue 12.04%
(FY 2023)
- Profit -42.19%
(FY 2023)
- Ebitda -16.58%
(FY 2023)
- Net Worth 4.40%
(FY 2023)
- Total Assets -21.29%
(FY 2023)
About Mediair Healthcare Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.61 Cr.
The company currently has active open charges totaling ₹6.02 Cr.
Sanjeev Mandholia, Meena Mandholia, Alisha Mandholia, and One other member serve as directors at the Company.
- CIN/LLPIN
U33100MH2017PTC295924
- Company No.
295924
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
Who are the key members and board of directors at Mediair Healthcare Products?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Mandholia  | Director | 07-Jun-2017 | Current |
| Meena Mandholia | Director | 07-Jun-2017 | Current |
| Alisha Mandholia | Director | 26-Mar-2018 | Current |
| Rohit Mandholia | Director | 06-Apr-2022 | Current |
Financial Performance of Mediair Healthcare Products.
Mediair Healthcare Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.04% increase. The company also saw a substantial fall in profitability, with a 42.19% decrease in profit. The company's net worth moved up by a moderate rise of 4.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediair Healthcare Products?
In 2023, Mediair Healthcare Products had a promoter holding of 63.11% and a public holding of 36.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ramjidas Nagarmal Consultants Private LimitedActive 29 years 6 monthsSanjeev Mandholia and Meena Mandholia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jun 2024 | ₹2.50 Cr | Open |
Others Creation Date: 31 May 2024 | ₹3.52 Cr | Open |
How Many Employees Work at Mediair Healthcare Products?
Mediair Healthcare Products has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediair Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediair Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
